In this report, the United States Enzyme-Linked Immunosorbent Assay (ELISA) market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Enzyme-Linked Immunosorbent Assay (ELISA) in these regions, from 2013 to 2025 (forecast).

United States Enzyme-Linked Immunosorbent Assay (ELISA) market competition by top manufacturers/players, with Enzyme-Linked Immunosorbent Assay (ELISA) sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
R&D Systems
Thermo Fisher Scientific
Ortho Clinical Diagnostics
BD Biosciences
ZEUS Scientific
Bio-Rad Laboratories
ALPCO
Enzo Life Sciences
BioMérieux
EMD Millipore
BioLegend
LOEWE Biochemica
Shenzhen YHLO Biotech

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
ELISA Sets
ELISA Kits
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
ELISA in HIV
ELISA in West Nile Virus
Detecting Antigens or Antibodies
Biodefense